Fluor-Designed and Built Plasma Fractionation Facility Awarded ISPE 2014 Facility of the Year for Project Execution
April 10 2014 - 4:37PM
Business Wire
World’s Largest Facility of its Kind Noted
for Superior Project Execution Using Modular Construction
Fluor Corporation (NYSE: FLR) announced today that Grifols’
North Fractionation Facility in Clayton, N.C., was named the
International Society for Pharmaceutical Engineering (ISPE) 2014
Facility of the Year for Project Execution.
Fluor designed and built this plasma
fractionation facility in North Carolina for Grifols that was
awarded ISPE's 2014 Facility of the Year for Project Execution.
(Photo: Business Wire)
Fluor provided integrated engineering, procurement, construction
management and front-end qualification for this 150,000-square-foot
plasma fractionation facility, which was built using modular
construction techniques to meet an aggressive construction
schedule, incorporate new centrifuge technology and expand existing
plant utilities.
“Fluor provides project management and execution excellence for
pharmaceutical and biotech clients across the globe, and the
Grifols blood plasma facility in North Carolina is a great example
of successful outcomes,” said Juan G. Hernandez, president of
Industrial Services for Fluor. “We provided Grifols with a single
point of project accountability, continuity of intent and
elimination of redundant project functions that resulted in a
state-of-the-art facility.”
“Grifols has very high standards, and we can always rely upon
the same high standards from Fluor in delivering our project
execution needs,” said Detlef Kehm, Grifols vice president of
engineering. “I am personally very pleased with ISPE’s independent
validation of this superior project and with Fluor’s
performance.”
ISPE’s judging panel was impressed with the delivery of the
facility in an aggressive time frame and under budget. This was
achieved with a high degree of collaboration within the teams and
because of early and consistent collaboration with European and
North American regulatory agencies, which facilitated the
qualification and validation process.
Grifols’ North Fractionation Facility in North Carolina is the
world’s largest and most technologically advanced of its kind. It
operates with a closed and fully automated manufacturing process in
an ambient environment to deliver life sciences products in the
safest, quality conscious and efficient manner. The primary project
achievements included the following:
- Provided a high-throughput
manufacturing facility while ensuring superior product quality
- Maximized yields while maintaining
product quality
- Lowered long-term operational
costs
- Delivered the facility in an aggressive
timeframe and under budget
Fluor-led projects have been chosen by ISPE for Facility of the
Year awards three times over the past five years.
For more details and a video on the Grifols North Fractionation
Facility project, visit
http://www.fluor.com/about_fluor/Pages/videos.aspx?channel=4&videoid=115.
About Grifols
Grifols is a global healthcare company with a 70-year legacy of
improving people's health and wellbeing through the development of
life-saving plasma medicines, diagnostics systems and hospital
pharmacy products. Additionally, Grifols has established an
independent engineering company, Grifols Engineering, SA. The
company is present in more than 100 countries worldwide and is
headquartered in Barcelona, Spain. In 2013, sales exceeded 2,740
million euros with a headcount of 13,200 employees. The company's
class A shares are listed on the Spanish Stock Exchange, where they
are part of the Ibex-35 (MCE:GRF). Its non-voting class B shares
are listed on the Mercado Continuo (MCE:GRF.P) and on the U.S.
NASDAQ via ADRs (NASDAQ: GRFS). For more information, visit
www.grifols.com.
About Fluor Corporation
Fluor Corporation (NYSE: FLR) is a global engineering and
construction firm that designs and builds some of the world's most
complex projects. The company creates and delivers innovative
solutions for its clients in engineering, procurement, fabrication,
construction, maintenance and project management on a global basis.
For more than a century, Fluor has served clients in the energy,
chemicals, government, industrial, infrastructure, mining and power
market sectors. Headquartered in Irving, Texas, Fluor ranks 110 on
the FORTUNE 500 list. With more than 40,000 employees worldwide,
the company's revenue for 2013 was $27.4 billion. Visit Fluor at
www.fluor.com and follow on Twitter @FluorCorp.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20140410006329/en/
Fluor CorporationMedia Relations:Brian Mershon,
469-398-7621orEric Krantz, 281-263-6030orInvestor Relations:Ken
Lockwood, 469-398-7220orJason Landkamer, 469-398-7222
Fluor (NYSE:FLR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fluor (NYSE:FLR)
Historical Stock Chart
From Sep 2023 to Sep 2024